Chembio Diagnostics, Inc. - CEMI
About Gravity Analytica
Recent News
- 07.29.2025 - FDA AWARDS BREAKTHROUGH DEVICE STATUS TO THE DPP® SYPHILIS TnT ASSAY
- 06.17.2025 - FDA Awards Breakthrough Device Status to the SURE CHECK® HIV Self-Test
- 10.23.2024 - Chembio Diagnostics Inc. receives a grant for Development of a DPP Congenital Syphilis Assay
Recent Filings
- 05.09.2023 - 15-12G Securities registration termination [Section 12(g)]
- 05.04.2023 - SC 13D/A General Statement of Acquisition of Beneficial Ownership
- 05.02.2023 - EFFECT Notice of Effectiveness
- 05.02.2023 - EFFECT Notice of Effectiveness
- 05.02.2023 - EFFECT Notice of Effectiveness
- 05.02.2023 - 4 Statement of changes in beneficial ownership of securities
- 05.02.2023 - EFFECT Notice of Effectiveness
- 05.02.2023 - EFFECT Notice of Effectiveness
- 05.01.2023 - 4 Statement of changes in beneficial ownership of securities
- 05.01.2023 - 4 Statement of changes in beneficial ownership of securities